Viral polymerase inhibitors
US8030309B2 · kind B2 · utility
3Cited by
48References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2010 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Sep 27, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I:wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.